ARKG · ARK Invest

ARK Genomic Revolution ETF

See how 33 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 30 April 2026Price US$54.00 as of 2 October 2026Holdings available · disclosure too old for reliability

Holdings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Core valuation

Trailing P/E-15.01×98.27% of 99.71% disclosed weight
Latest-quarter run-rate P/E-12.90×98.27% of 99.71% disclosed weight
Trailing P/S14.36×95.83% of 99.71% disclosed weight
Latest-quarter run-rate P/S14.92×95.83% of 99.71% disclosed weight

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 99.71% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

Largest reported ETF holdings with weights and trailing valuation ratios
HoldingWeightTrailing P/ETrailing P/S
TEMTEMPUS AI INC CL A9.42%-54.25×9.64×
TWSTTWIST BIOSCIENCE CORP COM8.99%-86.25×27.31×
CRSPCRISPR THERAPEUTICS AG NAMEN AKT8.91%-11.88×400.29×
TXG10X GENOMICS INC CL A COM5.77%-153.58×18.70×
BEAMBEAM THERAPEUTICS INC COM5.43%-29.12×16.15×
ABSIABSCI CORP COM4.78%-15.24×1181.84×
NTRANATERA INC COM4.07%-306.11×21.75×
ILMNILLUMINA INC COM4.03%48.63×8.93×
NTLAINTELLIA THERAPEUTICS INC COM3.82%-4.25×28.54×
PSNLPERSONALIS INC COM3.58%-16.11×24.79×

Top 10 of 33 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

  1. ARKG.L · ARK Genomic Revolution UCITS ETF84.68% holdings overlap · London Stock Exchange
  2. GNOM · Global X Genomics & Biotechnology ETF35.32% holdings overlap · Nasdaq
  3. ARKK.L · ARK Innovation UCITS ETF30.83% holdings overlap · London Stock Exchange
  4. ARKK · ARK Innovation ETF26.71% holdings overlap · Cboe BZX
  5. EKG · First Trust Nasdaq Lux Digital Health Solutions ETF23.20% holdings overlap · Nasdaq

Sources and limitations

Holdings are sourced from ARK Invest and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 30 April 2026. Informational research, not investment advice.